Insider Transactions in Q4 2022 at Arrowhead Pharmaceuticals, Inc. (ARWR)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2022
|
Kenneth Allen Myszkowski Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
30,625
-8.34%
|
$1,225,000
$40.0 P/Share
|
|
Dec 21
2022
|
Patrick O'Brien COO and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
32,000
+7.75%
|
$192,000
$6.15 P/Share
|
|
Dec 20
2022
|
Christopher Richard Anzalone Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
234,025
+5.92%
|
-
|
|
Dec 16
2022
|
Christopher Richard Anzalone Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,375
+0.52%
|
-
|
|
Nov 21
2022
|
Martin Javier San Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
19,500
-8.8%
|
$585,000
$30.3 P/Share
|